Appendix Table 3.
Risk Score–Specific Events Among Participants Who Had Coronary Revascularization*
| Event Status | Events, n (%) | |||
|---|---|---|---|---|
| FRS-CHD† | FRS-CVD‡ | ATPIII-FRS-CHD§ | AHA-ACC-ASCVD§ | |
| Revascularization after CHD event|| | 108 (58.70) | 114 (61.96) | 42 (22.83) | 43 (23.37) |
| Revascularization ≤48 h before CHD event¶ | 45 (24.46) | 45 (24.46) | 25 (13.59) | 25 (13.59) |
| Revascularization >48 h to ≤30 d before CHD event** | 4 (2.17) | 3 (1.63) | 5 (2.72) | 5 (2.72) |
| Revascularization >30 d before CHD event** | 5 (2.72) | 5 (2.72) | 3 (1.63) | 4 (2.17) |
| Revascularization with no CHD event** | 22 (11.96) | 17 (9.24) | 109 (59.24) | 107 (58.15) |
ACC = American College of Cardiology; AHA = American Heart Association; ASCVD = atherosclerotic cardiovascular disease; ATPIII = Adult Treatment Panel III; CHD = coronary heart disease; CVD = cardiovascular disease; FRS = Framingham risk score.
184 participants. CHD event is specific to each risk score. The Reynolds Risk Score was excluded from this analysis because revascularization was part of the end point.
Angina pectoris, nonfatal myocardial infarction, and coronary insufficiency.
Angina pectoris, nonfatal myocardial infarction, peripheral vascular disease, and heart failure.
Nonfatal myocardial infarction.
Event occurred after censoring and could not have contributed to overestimation.
Event was considered possibly periprocedural and was not considered in the evaluation of overestimation.
Events modeled as possibly explanatory for overestimation.